Irish National Institute for Bioprocessing Research and Training (NIBRT) and Waters Corporation announced today they have formed a multi-level partnership designed to support advanced concepts and deliver the promise of more effective biotherapeutic innovations addressing the world's most challenging diseases through both training and research.

Waters and NIBRT have established the Complete Product and Processing Characterization Facility (CPPCF) for hands-on laboratory based scientific training and retraining of ‘fit-for-purpose' biopharmaceutical analysis, including protein and peptide characterization. The CPPCF's goal is to provide comprehensive training of industry and governmental technicians and scientists to help the burgeoning industry develop  advanced biotherapeutic characterization The new facility will also educate scientists on existing and upcoming U.S. and European drug regulations. 

Furthermore, the partnership establishes NIBRT as a Waters Center of Innovation in the area of glycobiology research. Prof. Pauline Rudd, NIBRT's principal investigator, and her team will be working with Waters mass spectrometry based systems to take challenging glycan characterization to the next level. By improving understanding of glycan chemical and molecular structure, scientists can better understand safety and efficacy profiles for a potential molecule, leading directly to novel biotherapeutic options.

For further information visit www.waters.com